Accera Raises $35 Million

Accera Inc., a Broomfield, Colo.-based drug company focused on Alzheimer's disease and related neurodegenerative diseases, has raised $35 million in Series C funding. Inventages Venture Capital led the deal, and was joined by fellow return backers Posco BioVentures.

North AmericaUSBriefs